Results 11 to 20 of about 147,329 (251)

Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review [PDF]

open access: yesAnnals of Global Health
Background: Asbestos remains a significant global public health issue, with approximately 255,000 deaths attributed to exposure each year, primarily through occupational contact.
Camilo de la Pava-Cortés   +10 more
doaj   +2 more sources

An Evaluation of Mortality Rates and Their Determinants in a Cohort of Former Asbestos Miners in South Africa. [PDF]

open access: yesAm J Ind Med
ABSTRACT Background A causal association between occupational asbestos exposure and lung disease, including pneumoconiosis and mesothelioma, is well established. Elevated mortality among former asbestos miners is expected. However, large‐scale South African studies examining all‐cause mortality in this population are lacking.
Williams-Mohamed Y   +3 more
europepmc   +2 more sources

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice

open access: yesNature Communications, 2022
Immune checkpoint blockade (ICB) is partially successful as a cancer therapy. Here using mouse models, the authors transcriptionally monitor responding and non-responding tumours showing that responding tumours were associated with transient IFN-β ...
Rachael M. Zemek   +15 more
doaj   +1 more source

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment

open access: yesBMJ Global Health, 2022
Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is unknown if countries ban asbestos as a consequence of ARD burdens.
Seong-Kyu Kang   +10 more
doaj   +1 more source

The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection

open access: yesBMC Research Notes, 2017
Objective MicroRNAs are frequently downregulated in cancer, and restoring expression has tumour suppressive activity in tumour cells. Our recent phase I clinical trial investigated microRNA-based therapy in patients with malignant pleural mesothelioma ...
Patrick Winata   +5 more
doaj   +1 more source

Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model

open access: yesBMC Research Notes, 2020
Objective There is substantial evidence that exercise can safely reduce the risk of cancer and improve survival in different human cancer populations.
Scott A. Fisher   +6 more
doaj   +1 more source

Asbestos in Talc [PDF]

open access: yesEnvironmental Health Perspectives, 1974
Talc deposits include asbestos minerals such as chrysotile and amphiboles that may be carried over into consumer products. Optical microscopy and x-ray diffraction analyses may not reveal their presence. Examples are given of electron microscopy procedures that permit detection and measurement.
openaire   +2 more sources

Cell-free microRNAs: potential biomarkers in need of standardized reporting

open access: yesFrontiers in Genetics, 2013
MicroRNAs are abundantly present and surprisingly stable in multiple biological fluids. These findings have been followed by numerous of reports revealing the clinical potential of using microRNA levels in body fluids as a biomarker of disease. Despite a
Michaela B Kirschner   +2 more
doaj   +1 more source

MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients

open access: yesGenomics Data, 2016
Malignant pleural mesothelioma (MPM) is a tumor originating in the mesothelium, the membrane lining the thoracic cavities, and is induced by exposure to asbestos. Australia suffers one of the world's highest rates of MPM and the incidence is yet to peak.
Ruby C.Y. Lin   +4 more
doaj   +1 more source

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation

open access: yesFrontiers in Oncology, 2020
BackgroundThe diagnosis of malignant pleural mesothelioma (MPM) can be difficult, in part due to the difficulty in distinguishing between MPM and reactive mesothelial hyperplasia (RMH).
Yuen Yee Cheng   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy